# Boston Scientific Corporation clinical trials: 538 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 538 trials with Boston Scientific Corporation as lead sponsor, 39 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Boston Scientific Corporation: 538 rows for $26.90, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/boston-scientific-corporation

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 538
- Recruiting or not yet: 39
- Read on: November 19, 2026

## Trials

The 25 newest of 538, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07925359 | The Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Used With the FARAWAVE NAV™ ULTRA Pulsed... | Boston Scientific Corporation | Not applicable | Not yet recruiting | Atrial Fibrillation (AF), Paroxysmal AF, Persistent Atrial Fibrillation (PersAF), FARAPULSE | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925359) |
| October 9, 2026 | NCT07867886 | An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM | Boston Scientific Corporation | Not applicable | Not yet recruiting | Recurrent Glioblastoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867886) |
| September 15, 2026 | NCT07820930 | A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients... | Boston Scientific Corporation | Not applicable | Not yet recruiting | Atrial Fibrillation (AF), Persistent Atrial Fibrillation (PersAF), Paroxysmal Atrial Fibrillation (PAF) | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820930) |
| July 17, 2026 | NCT07711093 | Study of Eso-SPONGE for Treating Leaks After Upper Gastrointestinal Surgery | Boston Scientific Corporation | Not applicable | Not yet recruiting | Anastomotic Leaks | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711093) |
| June 25, 2026 | NCT07669727 | A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning. | Boston Scientific Corporation | Observational | Not yet recruiting | Hepatocellular Carcinoma (HCC) | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07669727) |
| June 10, 2026 | NCT07639684 | Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D) | Boston Scientific Corporation | Not applicable | Not yet recruiting | Type 2 Diabetes Mellitus (T2D), Obesity (BMI\>30) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07639684) |
| May 8, 2026 | NCT07575269 | Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation | Boston Scientific Corporation | Not applicable | Recruiting | Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation | 571 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575269) |
| April 17, 2026 | NCT07537478 | Respiration Measured Via End-tidal CO2 and Spirometry Study (RESPI) | Boston Scientific Corporation | Observational | Completed | Respiration Rate Detection | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07537478) |
| March 31, 2026 | NCT07502599 | Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE) | Boston Scientific Corporation | Observational | Recruiting | Orthostatic Hypotension, Reflex Syncope | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07502599) |
| March 9, 2026 | NCT07458243 | A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese Population | Boston Scientific Corporation | Observational | Not yet recruiting | Carotid Artery Stenosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07458243) |
| March 9, 2026 | NCT07458217 | Combined CM and STN Stimulation for Motor Epilepsy | Boston Scientific Corporation | Not applicable | Recruiting | Motor Epilepsy | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07458217) |
| March 6, 2026 | NCT07455747 | Real-World Treatment of Extracranial Carotid Artery Disease With the ENROUTE™ Transcarotid Neuroprotection System | Boston Scientific Corporation | Observational | Recruiting | Extracranial Carotid Artery Disease, TCAR, Transcarotid Artery Revascularization | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07455747) |
| March 2, 2026 | NCT07444320 | Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System | Boston Scientific Corporation | Not applicable | Recruiting | Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07444320) |
| January 30, 2026 | NCT07377487 | TheraSphere Japan Pre-Market Study | Boston Scientific Corporation | Not applicable | Recruiting | Liver Neoplasms | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07377487) |
| January 20, 2026 | NCT07353710 | A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation Procedure | Boston Scientific Corporation | Not applicable | Recruiting | Atrial Arrhythmia, Intracardiac Echocardiography | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07353710) |
| January 16, 2026 | NCT07349121 | OPTION-EMEA Clinical Trial | Boston Scientific Corporation | Not applicable | Recruiting | Atrial Fibrillation (AF), Stroke Prevention in Patients With Atrial Fibrillation, Left Atrial Appendage Closure, Pulsed... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07349121) |
| December 17, 2025 | NCT07287436 | Elite AF IDE Trial (Elite AF) | Boston Scientific Corporation | Not applicable | Recruiting | Atrial Fibrillation (AF), Stroke | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07287436) |
| December 11, 2025 | NCT07276815 | OverStitch NXT Endoscopic Suture System | Boston Scientific Corporation | Not applicable | Recruiting | Weight Loss | 136 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07276815) |
| December 3, 2025 | NCT07262255 | WATCHMAN FLX Pro European Registry | Boston Scientific Corporation | Observational | Active not recruiting | Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure | 189 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07262255) |
| October 7, 2025 | NCT07209852 | Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up | Boston Scientific Corporation | Observational | Active not recruiting | Bradycardia, Atrioventricular Block, Sinus Node Dysfunction, Bundle-Branch Block | 141 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07209852) |
| September 29, 2025 | NCT07195708 | Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365') | Boston Scientific Corporation | Not applicable | Recruiting | Weight Loss | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07195708) |
| September 24, 2025 | NCT07190807 | Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control | Boston Scientific Corporation | Not applicable | Recruiting | Chronic Pain, Intractable Pain, Low Back Pain, Chronic Low-back Pain, Chronic Leg Pain, Leg Pain | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07190807) |
| September 24, 2025 | NCT07190794 | RESCUE: Discontinuation of GLP-1 | Boston Scientific Corporation | Observational | Terminated | Obesity | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07190794) |
| September 22, 2025 | NCT07187115 | A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial... | Boston Scientific Corporation | Not applicable | Active not recruiting | Atrial Fibrillation (AF), Persistant Atrial Fibrillation | 699 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07187115) |
| August 6, 2025 | NCT07106970 | PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II) | Boston Scientific Corporation | Not applicable | Recruiting | Persistent Atrial Fibrillation | 640 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07106970) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 2 |
| Phase 1 | 9 |
| Phase 1/2 | 6 |
| Phase 2 | 13 |
| Phase 2/3 | 14 |
| Phase 3 | 43 |
| Phase 4 | 40 |
| Not applicable | 251 |
| Observational | 160 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 387 |
| Terminated | 58 |
| Recruiting | 32 |
| Active not recruiting | 31 |
| Withdrawn | 19 |
| Not yet recruiting | 7 |
| Suspended | 2 |
| Unknown | 1 |
| Enrolling by invitation | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Atrial Fibrillation | 64 |
| Heart Failure | 51 |
| Coronary Artery Disease | 46 |
| Chronic Pain | 33 |
| Atherosclerosis | 20 |
| Pain | 20 |
| Back Pain | 18 |
| Tachycardia, Ventricular | 16 |
| Cardiovascular Diseases | 16 |
| Aortic Valve Stenosis | 16 |
| Bradycardia | 15 |
| Arrhythmias, Cardiac | 15 |
| Ventricular Fibrillation | 14 |
| Stroke | 13 |
| Carcinoma, Hepatocellular | 12 |
| Varicose Veins | 11 |
| Prostatic Hyperplasia | 10 |
| Heart Diseases | 10 |
| Tachycardia | 10 |
| Parkinson Disease | 10 |
| Asthma | 9 |
| Neoplasms | 9 |
| Emphysema | 9 |
| Neoplasm Metastasis | 8 |
| Atrial Flutter | 8 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Veterans hospitals in the United States](https://specstream.ai/data/businesses/veterans-hospitals/united-states)
- [Banks in the United States](https://specstream.ai/data/businesses/banks/united-states)
- [Dental laboratories in the United States](https://specstream.ai/data/businesses/dental-laboratories/united-states)
- [Graphic design firms in the United States](https://specstream.ai/data/businesses/graphic-design-firms/united-states)
- [Mechanical engineering firms in the United States](https://specstream.ai/data/businesses/mechanical-engineering-firms/united-states)
- [Promotional products companies in the United States](https://specstream.ai/data/businesses/promotional-products-companies/united-states)
